Deep learning enhanced drug discovery for novel biomaterials in regenerative medicine utilizing graph neural network approach for predicting cellular responses
Downloads
Issue
Section
License
Copyright (c) 2024 The Scientific Temper
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This study introduces a novel approach to drug discovery in regenerative medicine through the utilization of a graph neural network (GNN). The research methodology integrates the development and training of the GNN with a subsequent evaluation of its performance metrics. The first phase involves the generation of synthetic data simulating a biological network, employing networkX and NumPy libraries to construct a random graph with Erdos-Renyi topology. The data, representing cellular responses to biomaterials, is then converted into PyTorch tensors for compatibility with the GNN architecture. The GNN model, characterized by two fully connected layers with ReLU and log-softmax activations, captures intricate relationships within the graph-structured data. The second phase employs a stochastic gradient descent algorithm, specifically the Adam optimizer, to train the GNN over 100 epochs using the cross-entropy loss for multi-class classification. The research methodology extends to the evaluation phase, producing three distinct output graphs for analysis: Visualization of the graph structure, a comparison between predicted and true labels, and a plot illustrating training loss over epochs. Performance metrics, including accuracy, precision, recall, and F1-score, are computed to assess the model’s predictive capabilities quantitatively. The study concludes with a discussion on the nuances revealed by each graph and their implications for refining GNN models in the context of drug discovery for regenerative medicine.Abstract
How to Cite
Downloads